论文部分内容阅读
６３例Ⅱ型糖尿病（ＮＩＤＤＭ）高脂血症患者随机分为治疗组和对照组。两组均口服达美康或美吡达控制血糖。治疗组则加用松龄血脉康，１次３粒，口服，每日３次，两组疗程均为５周。结果治疗组总有效率８６．８％，对照组总有效率４４．４％，两组疗效比较有非常显著性差异（Ｐ＜０．０１）；治疗前后血脂比较，治疗组ＴＣ、ＴＧ、ＬＤＬ－Ｃ下降（Ｐ＜０．０１），ＨＤＬ－Ｃ上升（Ｐ＜０．０５）。对照组ＴＣ、ＴＧ、ＬＤＬ－Ｃ、ＨＤＬ－Ｃ变化无显著性差异（Ｐ＞０．０５）。结论：松龄血脉康具有调节脂肪代谢的作用，对防治糖尿病血管并发症和改善预后有积极的意义
Sixty-three patients with type 2 diabetes (NIDDM) with hyperlipidemia were randomly divided into treatment and control groups. Both groups received oral administration of Delta Mecon or Mepitirol to control blood glucose. The treatment group was treated with Songling Xuemaikang, 3 capsules once orally, 3 times a day, and the duration of treatment in both groups was 5 weeks. Results The total effective rate was 86.8% in the treatment group and 44.4% in the control group. There was a significant difference in the efficacy between the two groups (P<0.01). The TC, TG, and LDL in the treatment group were compared before and after treatment. -C decreased (P <0.01), HDL-C increased (P <0.05). There was no significant difference in the changes of TC, TG, LDL-C and HDL-C in the control group (P>0.05). Conclusion: Songling Xuemaikang has the function of regulating fat metabolism and has positive significance in preventing and treating diabetic vascular complications and improving prognosis.